110 related articles for article (PubMed ID: 3500233)
1. Antibody conjugates with cobra venom factor. Synthesis and biochemical characterization.
Petrella EC; Wilkie SD; Smith CA; Morgan AC; Vogel CW
J Immunol Methods; 1987 Nov; 104(1-2):159-72. PubMed ID: 3500233
[TBL] [Abstract][Full Text] [Related]
2. Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation.
Zara J; Pomato N; McCabe RP; Bredehorst R; Vogel CW
Bioconjug Chem; 1995; 6(4):367-72. PubMed ID: 7578355
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate-directed conjugation of cobra venom factor to antibody by selective derivatization of the terminal galactose residues.
Fu Q; Gowda DC
Bioconjug Chem; 2001; 12(2):271-9. PubMed ID: 11312689
[TBL] [Abstract][Full Text] [Related]
4. Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.
Juhl H; Petrella EC; Cheung NK; Bredehorst R; Vogel CW
Immunobiology; 1997 Nov; 197(5):444-59. PubMed ID: 9413745
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach.
Juhl H; Sievers M; Baltzer K; Helmig F; Wolf H; Brenner W; Kalthoff H
Cancer Res; 1995 Dec; 55(23 Suppl):5749s-5755s. PubMed ID: 7493340
[TBL] [Abstract][Full Text] [Related]
6. Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic.
Juhl H; Petrella EC; Cheung NK; Bredehorst R; Vogel CW
Mol Immunol; 1990 Oct; 27(10):957-64. PubMed ID: 2233757
[TBL] [Abstract][Full Text] [Related]
7. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
[TBL] [Abstract][Full Text] [Related]
9. Cobra venom factor: structural homology with the third component of human complement.
Vogel CW; Smith CA; Müller-Eberhard HJ
J Immunol; 1984 Dec; 133(6):3235-41. PubMed ID: 6491285
[TBL] [Abstract][Full Text] [Related]
10. Absence of a neutralizing antibody response to humanized cobra venom factor in mice.
Ing M; Hew BE; Fritzinger DC; Delignat S; Lacroix-Desmazes S; Vogel CW; Rayes J
Mol Immunol; 2018 May; 97():1-7. PubMed ID: 29525557
[TBL] [Abstract][Full Text] [Related]
11. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
Vogel CW; Fritzinger DC
Curr Pharm Des; 2007; 13(28):2916-26. PubMed ID: 17979736
[TBL] [Abstract][Full Text] [Related]
12. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
13. The selective cytotoxicity of cobra venom factor immunoconjugate on cultured human nasopharyngeal carcinoma cell line.
Wang XM; Huang SJ
Hum Exp Toxicol; 1999 Feb; 18(2):71-6. PubMed ID: 10100018
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity and function of oligosaccharides in cobra venom factor.
Gowda DC; Petrella EC; Raj TT; Bredehorst R; Vogel CW
J Immunol; 1994 Mar; 152(6):2977-86. PubMed ID: 8144897
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of a complement-depleting factor from king cobra, Ophiophagus hannah.
Zeng L; Sun QY; Jin Y; Zhang Y; Lee WH; Zhang Y
Toxicon; 2012 Sep; 60(3):290-301. PubMed ID: 22561424
[TBL] [Abstract][Full Text] [Related]
16. Purification of native and recombinant cobra venom factor using thiophilic adsorption chromatography.
Kölln J; Braren I; Bredehorst R; Spillner E
Protein Pept Lett; 2007; 14(5):475-80. PubMed ID: 17584174
[TBL] [Abstract][Full Text] [Related]
17. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus.
Rehana S; Manjunatha Kini R
Toxicon; 2007 Jul; 50(1):32-52. PubMed ID: 17412383
[TBL] [Abstract][Full Text] [Related]
18. Cobra venom factor: improved method for purification and biochemical characterization.
Vogel CW; Müller-Eberhard HJ
J Immunol Methods; 1984 Oct; 73(1):203-20. PubMed ID: 6491300
[TBL] [Abstract][Full Text] [Related]
19. Preparation of immunoconjugates using antibody oligosaccharide moieties.
Vogel CW
Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
Kölln J; Matzas M; Jänner N; Mix T; Klensang K; Bredehorst R; Spillner E
Mol Immunol; 2004 May; 41(1):19-28. PubMed ID: 15140572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
